ADVL1412: A Phase 1/2 Study of Nivolumab in Children, Adolescents and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/157/31/20

Funding

  • Children's Hospital of Philadelphia (MA-I:FP00012931_SUB197-01)
  • Bristol-Myers Squibb Company (MA-I:FP00012931_SUB197-01)